Korify Capital

Total investments

22

Average round size

44M

Portfolio companies

18

Rounds per year

7.33

Follow on index

0.18

Exits

2

Stages of investment
Late Stage Venture
Areas of investment
BiotechnologyE-CommerceConsumer GoodsArtificial IntelligenceHealth CareHealth DiagnosticsMedicalLife ScienceNeuroscienceBiopharma

Investments analytics

Analytics

Total investments
22
Lead investments
0
Exits
2
Rounds per year
7.33
Follow on index
0.18
Investments by industry
  • Biotechnology (7)
  • Biopharma (6)
  • Consumer Goods (5)
  • E-Commerce (5)
  • Life Science (4)
  • Show 21 more
Investments by region
  • Cayman Islands (1)
  • United States (9)
  • United Kingdom (2)
  • Germany (3)
  • Mexico (2)
  • Show 2 more
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
4
Avg. valuation at time of investment
100M
Group Appearance index
0.59
Avg. company exit year
22
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Samsara Therapeutics 15 Jul 2021 Biotechnology, Life Science, Pharmaceutical, Biopharma Early Stage Venture 10M United States, Massachusetts, Boston
Wonder brands 17 Aug 2023 E-Commerce, Consumer Goods Early Stage Venture 15M Mexico City, Mexico

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.